Keith Manchester - Insider Trading & Ownership

Entity
Individual
Location
C/O Roivant Sciences Ltd., 11 12 St. James's Square Suite 1, 3 Rd Fl, London, United Kingdom
Summary
The estimated net worth of Keith Manchester is at least $15.2M dollars as of September 26, 2024. Keith Manchester is the Director of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $15M. Keith Manchester is the Director of Arbutus Biopharma Corp and owns shares of Arbutus Biopharma Corp (ABUS) stock worth about $170K.
All Insider Reports
All Insider Reports

Ownership of Keith Manchester

Insider Transactions Reported by Keith Manchester:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.